07 November 2007
The hypoglycemic action of glimepiride in the diabetic liver cirrhosis patients, report of 4 cases
Putut Bayupurnama, Siti NurdjanahCase Rep Clin Pract Rev 2007; 8:266-268 :: ID: 519378
Abstract
Background: Sulfonylurea treatment of diabetic liver cirrhosis (LC) patients is still controversial. The pharmacokinetic of glimepiride does not change in the LC disease. Aim of the study is to report our experience prescribing glimepiride in the diabetic LC patients who had lack of compliance with or refuse insulin treatment.
Case Report: This case study involved four diabetic and ascitic LC patients with fasting plasma glucose (FPG) ≥ 6.99 mmol/L, with lack of compliance with or refuse insulin treatment, serum creatinine level less than 132.6 μmol/L, and approved glimepiride treatment (started with 1mg/day and then increase to 2 or 3 mg/day if needed ,before meal in the morning). FPG and 2-hour postprandial (2PP) were measured before , periodically,and at the end of treatment. The treatment duration were 24 weeks in one patient and 48 weeks in 3 patients.
In general, the glimepiride lowered the fasting plasma glucose level although it did not show consistent results in all patients. Only one patient showed good control, even asymptomatic hypoglycemia, of FPG level at the end of 48 weeks of treatment. On the other hand, the 2PP level results were inconsistent and the mean value were still high.
Conclusions: Glimepiride treatment lowered fasting plasma glucose level inconsistently and did not show favorable respond to the 2-hour postprandial level in diabetic liver cirrhosis patients. Higher dose of glimepiride may be needed and clinical trial should be performed to confirm the benefit, risk and safety profile of this treatment.
Keywords: Diabetic Diet, Liver Cirrhosis, Insulin Resistance
Editorial
01 October 2023 : Editorial
Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air PollutionDOI: 10.12659/MSM.942672
Med Sci Monit 2023; 29:e942672
In Press
04 Oct 2023 : Clinical Research
A Retrospective Study of 205 Patients with Complex Kidney Stones to Compare Outcomes from Super-Mini Percut...Med Sci Monit In Press; DOI: 10.12659/MSM.941012
03 Oct 2023 : Clinical Research
Prevalence and Risk Factors for Modic Changes in Symptomatic Cervical Ossification of the Posterior Longitu...Med Sci Monit In Press; DOI: 10.12659/MSM.941674
03 Oct 2023 : Clinical Research
Time-Dependent Factors Influencing Cardiocerebral Vascular Events in Chronic Hemodialysis Patients: Insight...Med Sci Monit In Press; DOI: 10.12659/MSM.941553
02 Oct 2023 : Clinical Research
Comparison of Nanocrystalline Hydroxyapatite Bone Graft with Empty Defects in Long Bone Fractures: A Retros...Med Sci Monit In Press; DOI: 10.12659/MSM.941112
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292